Search

Are you ready? How audiologists’ readiness for change relates to the implementation of remote care

Are we ready to deliver remote care? A question many of us have asked ourselves over the last year. Danielle Glista (Associate Professor, Western University) and colleagues talk through a systematic approach to implementing remote audiological care and suggest gaps...

Lights, camera, hearing: cinema as a catalyst for cochlear implant awareness

Cinema is reshaping how we see cochlear implants – raising awareness, sparking conversation and showing the power of representation. Cinema wields immense power in shaping societal perceptions and sparking dialogue around medical and social issues. In the realm of hearing...

Dementia assessments for people with deafness, deafblindness or visual impairment in Scotland

How is the medical community doing with assessing cognitive decline in those with a sensory impairment? The ALLIANCE Scottish Sensory Hub was tasked with finding out. Background There is growing evidence of a connection between dementia and sensory loss. However,...

ENT and evidence-based medicine: How do they benefit each other?

How do we assess evidence, and how should ENT surgeons use EBM? Evidence-based medicine (EBM) is the practice of medicine based upon high quality scientific research. There are several formal definitions of EBM, the most widely quoted being that of...

Pre-clinical development of magnetic delivery of therapy to middle and inner ears

Why are we developing this technology? A key problem in drug delivery is getting the therapy to the right place in the body, which is especially challenging for targets that are small, deep and are protected or surrounded by anatomical...

Imaging in hyperparathyroidism

Following their caudal migration at eight weeks of development, the parathyroid glands normally locate posterolaterally to the upper pole of the thyroid gland at the level of the cricoid cartilage (superior parathyroid glands arising from the fourth branchial pouch and...

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....